世界のTDS(経皮デリバリーシステム)市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC11289)
◆英語タイトル:Global TDS(Transdermal Delivery Systems) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC11289
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、TDS(経皮デリバリーシステム)の世界市場を調査対象にし、TDS(経皮デリバリーシステム)の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(単層接着剤、多層接着剤、その他)、用途別分析(病院、クリニック、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Adhex Pharma、Teikoku Seiyaku、Toyochem、Harro Hofliger、IBSA Group、Tesa Labtec、Hisamitsu、Pfizer、Teva Pharmaceutical、Endo International、Mylan、Sorrento Therapeutics
・メーカー別販売量、売上、市場シェア
・TDS(経皮デリバリーシステム)の地域別市場分析
・TDS(経皮デリバリーシステム)の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・TDS(経皮デリバリーシステム)のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・TDS(経皮デリバリーシステム)のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・TDS(経皮デリバリーシステム)の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・TDS(経皮デリバリーシステム)の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・TDS(経皮デリバリーシステム)の種類別市場規模2015-2020:単層接着剤、多層接着剤、その他
・TDS(経皮デリバリーシステム)の用途別市場規模2015-2020:病院、クリニック、その他
・TDS(経皮デリバリーシステム)の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The global TDS(Transdermal Delivery Systems) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The TDS(Transdermal Delivery Systems) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
TDS(Transdermal Delivery Systems) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, TDS(Transdermal Delivery Systems) market has been segmented into
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others

By Application, TDS(Transdermal Delivery Systems) has been segmented into:
Hospital
Clinic
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global TDS(Transdermal Delivery Systems) market presented in the report. This section sheds light on the sales growth of different regional and country-level TDS(Transdermal Delivery Systems) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global TDS(Transdermal Delivery Systems) market.

The report offers in-depth assessment of the growth and other aspects of the TDS(Transdermal Delivery Systems) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and TDS(Transdermal Delivery Systems) Market Share Analysis
TDS(Transdermal Delivery Systems) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, TDS(Transdermal Delivery Systems) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the TDS(Transdermal Delivery Systems) sales, revenue and market share for each player covered in this report.

The major players covered in TDS(Transdermal Delivery Systems) are:
Adhex Pharma
Teikoku Seiyaku
Toyochem
Harro Hofliger
IBSA Group
Tesa Labtec
Hisamitsu
Pfizer
Teva Pharmaceutical
Endo International
Mylan
Sorrento Therapeutics

Among other players domestic and global, TDS(Transdermal Delivery Systems) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe TDS(Transdermal Delivery Systems) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of TDS(Transdermal Delivery Systems), with price, sales, revenue and global market share of TDS(Transdermal Delivery Systems) in 2018 and 2019.
Chapter 3, the TDS(Transdermal Delivery Systems) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TDS(Transdermal Delivery Systems) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, TDS(Transdermal Delivery Systems) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe TDS(Transdermal Delivery Systems) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 TDS(Transdermal Delivery Systems) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global TDS(Transdermal Delivery Systems) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single-layer Drug-in-Adhesive
1.2.3 Multi-layer Drug-in-Adhesive
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global TDS(Transdermal Delivery Systems) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global TDS(Transdermal Delivery Systems) Market
1.4.1 Global TDS(Transdermal Delivery Systems) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Adhex Pharma
2.1.1 Adhex Pharma Details
2.1.2 Adhex Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Adhex Pharma SWOT Analysis
2.1.4 Adhex Pharma Product and Services
2.1.5 Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teikoku Seiyaku
2.2.1 Teikoku Seiyaku Details
2.2.2 Teikoku Seiyaku Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teikoku Seiyaku SWOT Analysis
2.2.4 Teikoku Seiyaku Product and Services
2.2.5 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Toyochem
2.3.1 Toyochem Details
2.3.2 Toyochem Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Toyochem SWOT Analysis
2.3.4 Toyochem Product and Services
2.3.5 Toyochem TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Harro Hofliger
2.4.1 Harro Hofliger Details
2.4.2 Harro Hofliger Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Harro Hofliger SWOT Analysis
2.4.4 Harro Hofliger Product and Services
2.4.5 Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 IBSA Group
2.5.1 IBSA Group Details
2.5.2 IBSA Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 IBSA Group SWOT Analysis
2.5.4 IBSA Group Product and Services
2.5.5 IBSA Group TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Tesa Labtec
2.6.1 Tesa Labtec Details
2.6.2 Tesa Labtec Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Tesa Labtec SWOT Analysis
2.6.4 Tesa Labtec Product and Services
2.6.5 Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hisamitsu
2.7.1 Hisamitsu Details
2.7.2 Hisamitsu Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hisamitsu SWOT Analysis
2.7.4 Hisamitsu Product and Services
2.7.5 Hisamitsu TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical SWOT Analysis
2.9.4 Teva Pharmaceutical Product and Services
2.9.5 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Endo International
2.10.1 Endo International Details
2.10.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Endo International SWOT Analysis
2.10.4 Endo International Product and Services
2.10.5 Endo International TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mylan SWOT Analysis
2.11.4 Mylan Product and Services
2.11.5 Mylan TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sorrento Therapeutics
2.12.1 Sorrento Therapeutics Details
2.12.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sorrento Therapeutics SWOT Analysis
2.12.4 Sorrento Therapeutics Product and Services
2.12.5 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global TDS(Transdermal Delivery Systems) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global TDS(Transdermal Delivery Systems) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 TDS(Transdermal Delivery Systems) Manufacturer Market Share in 2019
3.3.2 Top 6 TDS(Transdermal Delivery Systems) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Regions
4.1.1 Global TDS(Transdermal Delivery Systems) Sales and Market Share by Regions (2015-2020)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue and Market Share by Regions (2015-2020)
4.2 North America TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.3 Europe TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.5 South America TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
5.1.1 North America TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
5.1.2 North America TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
5.2 United States TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
5.3 Canada TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
5.4 Mexico TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
6.1.1 Europe TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
6.1.2 Europe TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
6.2 Germany TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.3 UK TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.4 France TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.5 Russia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
6.6 Italy TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific TDS(Transdermal Delivery Systems) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific TDS(Transdermal Delivery Systems) Revenue and Market Share by Regions (2015-2020)
7.2 China TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.3 Japan TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.4 Korea TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.5 India TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
7.7 Australia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
8.1.1 South America TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
8.1.2 South America TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
8.2 Brazil TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
8.3 Argentina TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa TDS(Transdermal Delivery Systems) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa TDS(Transdermal Delivery Systems) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa TDS(Transdermal Delivery Systems) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9.3 Turkey TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9.4 Egypt TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
9.5 South Africa TDS(Transdermal Delivery Systems) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global TDS(Transdermal Delivery Systems) Sales and Market Share by Type (2015-2020)
10.2 Global TDS(Transdermal Delivery Systems) Revenue and Market Share by Type (2015-2020)
10.3 Global TDS(Transdermal Delivery Systems) Price by Type (2015-2020)
11 Global TDS(Transdermal Delivery Systems) Market Segment by Application
11.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
11.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2015-2020)
11.3 Global TDS(Transdermal Delivery Systems) Price by Application (2015-2020)
12 Market Forecast
12.1 Global TDS(Transdermal Delivery Systems) Sales, Revenue and Growth Rate (2021-2025)
12.2 TDS(Transdermal Delivery Systems) Market Forecast by Regions (2021-2025)
12.2.1 North America TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.2 Europe TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.3 Asia-Pacific TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.4 South America TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.2.5 Middle East & Africa TDS(Transdermal Delivery Systems) Market Forecast (2021-2025)
12.3 TDS(Transdermal Delivery Systems) Market Forecast by Type (2021-2025)
12.3.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2021-2025)
12.3.2 Global TDS(Transdermal Delivery Systems) Market Share Forecast by Type (2021-2025)
12.4 TDS(Transdermal Delivery Systems) Market Forecast by Application (2021-2025)
12.4.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2021-2025)
12.4.2 Global TDS(Transdermal Delivery Systems) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のTDS(経皮デリバリーシステム)市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global TDS(Transdermal Delivery Systems) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。